These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10951192)

  • 1. Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics.
    Sich C; Improta S; Cowley DJ; Guenet C; Merly JP; Teufel M; Saudek V
    Eur J Biochem; 2000 Sep; 267(17):5342-55. PubMed ID: 10951192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-timescale dynamics study of FKBP12 along the rapamycin-mTOR binding coordinate.
    Sapienza PJ; Mauldin RV; Lee AL
    J Mol Biol; 2011 Jan; 405(2):378-94. PubMed ID: 21073880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Entropy of FK506 Binding to FKBP12 Determined by Nuclear Magnetic Resonance Relaxation and Molecular Dynamics Simulations.
    Solomentsev G; Diehl C; Akke M
    Biochemistry; 2018 Mar; 57(9):1451-1461. PubMed ID: 29412644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes.
    Yang CJ; Takeda M; Terauchi T; Jee J; Kainosho M
    Biochemistry; 2015 Dec; 54(47):6983-95. PubMed ID: 26561008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition.
    Brath U; Akke M
    J Mol Biol; 2009 Mar; 387(1):233-44. PubMed ID: 19361439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.
    Zhao L; Huang W; Liu H; Wang L; Zhong W; Xiao J; Hu Y; Li S
    J Med Chem; 2006 Jul; 49(14):4059-71. PubMed ID: 16821768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of Aromatic Side Chains in the Active Site of FKBP12.
    Weininger U; Modig K; Geitner AJ; Schmidpeter PA; Koch JR; Akke M
    Biochemistry; 2017 Jan; 56(1):334-343. PubMed ID: 27936610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraligand hydrophobic interactions rationalize drug affinities for peptidyl-prolyl cis-trans isomerase protein.
    Bizzarri M; Marsili S; Procacci P
    J Phys Chem B; 2011 May; 115(19):6193-201. PubMed ID: 21500789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. II. Dissociation free energies in drug-receptor systems via nonequilibrium alchemical simulations: application to the FK506-related immunophilin ligands.
    Nerattini F; Chelli R; Procacci P
    Phys Chem Chem Phys; 2016 Jun; 18(22):15005-18. PubMed ID: 27193181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Aryl-2,2-difluoroacetamide FKBP12 ligands: synthesis and X-ray structural studies.
    Dubowchik GM; Vrudhula VM; Dasgupta B; Ditta J; Chen T; Sheriff S; Sipman K; Witmer M; Tredup J; Vyas DM; Verdoorn TA; Bollini S; Vinitsky A
    Org Lett; 2001 Dec; 3(25):3987-90. PubMed ID: 11735566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysing the visible conformational substates of the FK506-binding protein FKBP12.
    Mustafi SM; Chen H; Li H; Lemaster DM; Hernández G
    Biochem J; 2013 Aug; 453(3):371-80. PubMed ID: 23688288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.
    Wen H; Kang S; Song Y; Song Y; Yang HJ; Kim MH; Park S
    Arch Biochem Biophys; 2012 Jan; 517(1):37-42. PubMed ID: 22100703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of the RyR1-FKBP12 interaction.
    Samsó M; Shen X; Allen PD
    J Mol Biol; 2006 Mar; 356(4):917-27. PubMed ID: 16405911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of conformational transitions in the active site and 80's loop in the FK506-binding protein FKBP12.
    Mustafi SM; Brecher M; Zhang J; Li H; Lemaster DM; Hernández G
    Biochem J; 2014 Mar; 458(3):525-36. PubMed ID: 24405377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The full electron structure of the FKBP12/FK506 complex.
    Rossetto AM; Zhou W; Pang X; Zhou L
    J Biomol Struct Dyn; 2015; 33(2):388-94. PubMed ID: 24471694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity.
    Voll AM; Meyners C; Taubert MC; Bajaj T; Heymann T; Merz S; Charalampidou A; Kolos J; Purder PL; Geiger TM; Wessig P; Gassen NC; Bracher A; Hausch F
    Angew Chem Int Ed Engl; 2021 Jun; 60(24):13257-13263. PubMed ID: 33843131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pose scoring by NMR.
    Wang B; Raha K; Merz KM
    J Am Chem Soc; 2004 Sep; 126(37):11430-1. PubMed ID: 15366876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).
    Itoh S; Navia MA
    Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.
    Stebbins JL; Zhang Z; Chen J; Wu B; Emdadi A; Williams ME; Cashman J; Pellecchia M
    J Med Chem; 2007 Dec; 50(26):6607-17. PubMed ID: 18038971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural coupling between FKBP12 and buried water.
    Szep S; Park S; Boder ET; Van Duyne GD; Saven JG
    Proteins; 2009 Feb; 74(3):603-11. PubMed ID: 18704951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.